Abstract
We report that 4-(3-(benzyloxy)phenyl)-2-ethylsulfinyl-6-(trifluoromethyl)pyrimidine (BETP), which behaves as a positive allosteric modulator at the glucagon-like peptide-1 receptor (GLP-1R), covalently modifies cysteines 347 and 438 in GLP-1R. C347, located in intracellular loop 3 of GLP-1R, is critical to the activity of BETP and a structurally distinct GLP-1R ago-allosteric modulator, N-(tert-butyl)-6,7-dichloro-3-(methylsulfonyl)quinoxalin-2-amine. We further show that substitution of cysteine for phenylalanine 345 in the glucagon receptor is sufficient to confer sensitivity to BETP.
MeSH terms
-
Animals
-
CHO Cells
-
Cricetulus
-
Cysteine / chemistry
-
Glucagon-Like Peptide 1 / agonists
-
Glucagon-Like Peptide-1 Receptor
-
Humans
-
Ligands
-
Pyrimidines / chemistry*
-
Pyrimidines / metabolism
-
Receptors, Glucagon / chemistry
-
Receptors, Glucagon / metabolism*
Substances
-
4-(3-(benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine
-
GLP1R protein, human
-
Glucagon-Like Peptide-1 Receptor
-
Ligands
-
Pyrimidines
-
Receptors, Glucagon
-
Glucagon-Like Peptide 1
-
Cysteine
Associated data
-
PubChem-Substance/183814150
-
PubChem-Substance/183814151
-
PubChem-Substance/183814152
-
PubChem-Substance/183814153
-
PubChem-Substance/183814154